• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

文化程度较低与痴呆患者停止使用抗胆碱酯酶药物相关。

Less education predicts anticholinesterase discontinuation in dementia patients.

机构信息

College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

出版信息

Can J Neurol Sci. 2013 Sep;40(5):684-90. doi: 10.1017/s031716710001492x.

DOI:10.1017/s031716710001492x
PMID:23968942
Abstract

OBJECTIVE

We investigated patient socio-demographic, clinical and functional factors predicting cholinesterase inhibitor discontinuation by patients presenting to a memory clinic in Saskatoon, Saskatchewan.

METHODS

Data collection began in March 2004 at the Rural and Remote Memory Clinic where family physicians referred their non-institutionalized patients. Neurological and neuropsychological assessment, patient and caregiver questionnaires provided the socio-demographic, clinical and functional variables. Univariate logistic regression analysis was used to examine possible associations between each independent variable and the binary outcome variable of treatment discontinuation. Multivariate logistic regression was used to determine predictors of cholinesterase inhibitor discontinuation within six months of drug initiation.

RESULTS

Our sample consisted of the first 63 patients (60.3% female) for whom we prescribed a cholinesterase inhibitor. The mean age at clinic day was 74.56 years (SD=7.78). We found that years of formal education was the only variable significantly associated with cholinesterase inhibitor discontinuation by six months. The more years of formal education, the lower the rate of drug discontinuation by six months.

CONCLUSIONS

Likelihood of cholinesterase inhibitor discontinuation by six months was predicted by fewer years of formal education.

摘要

目的

我们调查了萨斯喀彻温省萨斯卡通的记忆诊所就诊患者的社会人口统计学、临床和功能因素,这些因素预测了他们停止使用胆碱酯酶抑制剂。

方法

数据收集始于 2004 年 3 月,在农村和远程记忆诊所,家庭医生将他们的非住院患者转介过来。神经学和神经心理学评估、患者和护理人员问卷调查提供了社会人口统计学、临床和功能变量。单变量逻辑回归分析用于检查每个独立变量与治疗中断的二项结果变量之间可能存在的关联。多变量逻辑回归用于确定在开始药物治疗后六个月内停止使用胆碱酯酶抑制剂的预测因素。

结果

我们的样本包括了前 63 名(60.3%为女性)患者,我们为他们开了胆碱酯酶抑制剂。诊所就诊日的平均年龄为 74.56 岁(SD=7.78)。我们发现,受正规教育年限是与六个月内停止使用胆碱酯酶抑制剂唯一显著相关的变量。受正规教育年限越长,六个月内停药的比例越低。

结论

受正规教育年限较少可预测六个月内停止使用胆碱酯酶抑制剂的可能性。

相似文献

1
Less education predicts anticholinesterase discontinuation in dementia patients.文化程度较低与痴呆患者停止使用抗胆碱酯酶药物相关。
Can J Neurol Sci. 2013 Sep;40(5):684-90. doi: 10.1017/s031716710001492x.
2
Predictors of cognitive impairment severity in rural patients at a memory clinic.农村患者在记忆诊所认知障碍严重程度的预测因素。
Can J Neurol Sci. 2012 Nov;39(6):774-81. doi: 10.1017/s0317167100015602.
3
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.轻度至中度痴呆症中胆碱酯酶抑制剂的成本效益:一种支付意愿方法。
CNS Drugs. 2003;17(14):1045-57. doi: 10.2165/00023210-200317140-00004.
4
Clinical practice with antidementia drugs in a geriatric clinic.老年诊所中抗痴呆药物的临床应用
J Med Assoc Thai. 2012 Aug;95(8):1081-9.
5
Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.胆碱酯酶抑制剂治疗期间脑白质变化与痴呆进展速度:一项回顾性队列研究。
Int J Geriatr Psychiatry. 2007 Nov;22(11):1120-6. doi: 10.1002/gps.1799.
6
Medication adherence in patients with dementia: an Austrian cohort study.痴呆症患者的药物依从性:一项奥地利队列研究。
Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):128-33. doi: 10.1097/WAD.0000000000000006.
7
A comparison of caregiver burden in older persons and persons with Parkinson's disease or dementia in sub-Saharan Africa.撒哈拉以南非洲地区老年人与帕金森病或痴呆症患者的照料者负担比较。
Int Psychogeriatr. 2014 Apr;26(4):687-92. doi: 10.1017/S104161021300255X. Epub 2014 Feb 10.
8
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors.老年痴呆症患者使用胆碱酯酶抑制剂治疗时的治疗空白期的影响。
Neurology. 2012 Mar 27;78(13):957-63. doi: 10.1212/WNL.0b013e31824d5773. Epub 2012 Mar 14.
9
Discontinuation of rivastigmine in routine clinical practice.
Int J Geriatr Psychiatry. 2005 Dec;20(12):1167-71. doi: 10.1002/gps.1411.
10
Quality of life in dementia: the role of non-cognitive factors in the ratings of people with dementia and family caregivers.痴呆患者的生活质量:非认知因素在痴呆患者和家庭照顾者评分中的作用。
Int Psychogeriatr. 2013 Jul;25(7):1097-105. doi: 10.1017/S1041610213000410. Epub 2013 Apr 8.

引用本文的文献

1
Persistence with anti-dementia medications: a systematic review and meta-analysis.抗痴呆药物的持续使用:一项系统评价与荟萃分析
Age Ageing. 2025 May 31;54(6). doi: 10.1093/ageing/afaf151.
2
Inequalities in the Quality and Safety of Post-Diagnostic Primary Care for People With Dementia: A Scoping Review.痴呆症患者诊断后初级保健质量与安全方面的不平等:一项范围综述。
Int J Geriatr Psychiatry. 2024 Dec;39(12):e70035. doi: 10.1002/gps.70035.
3
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.
痴呆症药物治疗的持续性和依从性:患者、医疗服务提供者及系统因素的相关性
Can J Psychiatry. 2014 Dec;59(12):624-31. doi: 10.1177/070674371405901203.
4
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.一项针对欧洲轻度至中度阿尔茨海默病患者使用抗痴呆药物持续性的 2 年前瞻性队列研究:ICTUS 研究中停药和换药的预测因素。
CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3.